Results 51 to 60 of about 7,444 (161)

Comparative study of safety and efficacy of labetalol and nifedipine in the management of hypertensive disorders of pregnancy: A prospective observational study [PDF]

open access: yesAl Ameen Journal of Medical Sciences
Background: Hypertensive disorders of pregnancy is a leading cause of maternal and fetal morbidity and mortality. Antihypertensive agents such as labetalol and nifedipine are commonly used, but comparative data on their effectiveness and safety are still
Syed Sujat Pasha, Shifa Roohi
doaj  

Comparison of the Effects of Dexmedetomidine and Labetalol on Controlled Hypotension in Maxillofacial Surgery

open access: yesJournal of Ardabil University of Medical Sciences, 2020
Background & objectives: The use of controlled hypotension is important to reduce bleeding in some surgeries. This study aimed to determine the effects of dexmedetomidine (DEX) and labetalol for induced hypotension in maxillofacial fractures surgery ...
Ali Alizadeh   +5 more
doaj  

Ancestry‐based antihypertensive therapy: Beware of pitfalls

open access: yes
Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 8, Page 1414-1416, August 2026.
Meryam Sugulle, Patji Alnæs‐Katjavivi
wiley   +1 more source

Blood Pressure Control With Clevidipine Is Associated With Hematoma Volume Reduction in Acute Hypertensive Intracerebral Hemorrhage: A Single‐Center Prospective Cohort Study

open access: yesEuropean Journal of Neurology, Volume 33, Issue 7, July 2026.
In this prospective cohort study of 64 patients with hypertensive intracerebral hemorrhage, intravenous clevidipine administration achieved rapid blood pressure control and was associated with greater 24‐h hematoma volume reduction compared with standard antihypertensive therapy (14.7% vs. 4.5% in controls).
Angeliki‐Erato Sterpi   +12 more
wiley   +1 more source

Effectiveness comparison of nifedipine, methyldopa, and labetalol in severe preeclampsia: A systematic review

open access: yesMajalah Obstetri dan Ginekologi
HIGHLIGHTS • All three medications (nifedipine, methyldopa, and labetalol) are viable first-line options for treating severe preeclampsia in pregnanc • Oral nifedipine may be faster at lowering blood pressure in severe preeclampsia than methyldopa or ...
Bambang Rahardjo   +2 more
doaj   +1 more source

Comparison of Oral Preoperative Clonidine with Infusion of Intraoperative Labetalol on Bleeding during Tympanoplasty Surgery [PDF]

open access: yesIranian Journal of Otorhinolaryngology
Introduction: Surgical bleeding is one of the most critical complications in various surgical procedures. In middle ear surgery, managing bleeding is a significant challenge for anesthesiologists because even minor bleeding can obstruct the surgeon's ...
Mohamad Reza Afzalzadeh   +3 more
doaj   +1 more source

Wearable Real‐Time Translation in Rhinology: A Comparative Study of Accuracy and Efficiency

open access: yes
International Forum of Allergy &Rhinology, Volume 16, Issue 7, Page 743-745, July 2026.
Emma J. Anisman   +12 more
wiley   +1 more source

In Vitro Assessment of Clevidipine Using the Profilin1 Hypertensive Mouse Model

open access: yesPharmaceuticals, 2013
Hypertension represents a major risk factor for cardiovascular events, associating with vascular hypertrophy and dysfunction in resistance vessels. Clevidipine is a novel antihypertensive drug working as a selective calcium channel antagonist with an ...
Hamdy H. Hassanain   +6 more
doaj   +1 more source

Labetalol Versus Methyldopa: Comparison of Frequency of Small for Gestational Age in the Treatment of Pregnancy Induced Hypertension

open access: yesJournal of Rawalpindi Medical College, 2018
Background: To compare the frequency of small for gestational age(SGA) babies between women treated with labetalol or methyldopa for pregnancy induced hypertension.
Shabana Kalsoom   +3 more
doaj  

Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial

open access: yesBMJ Open, 2013
Objective To compare the efficacy of Food and Drug Administration recommended dosing of nicardipine versus labetalol for the management of hypertensive patients with signs and/or symptoms (S/S) suggestive of end-organ damage (EOD).Design Secondary ...
Brian Hiestand   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy